No abstract available
MeSH terms
-
Administration, Oral
-
Anticoagulants / administration & dosage
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
Arthroplasty, Replacement, Hip / adverse effects*
-
Arthroplasty, Replacement, Knee / adverse effects*
-
Benzimidazoles / administration & dosage
-
Benzimidazoles / adverse effects
-
Benzimidazoles / therapeutic use*
-
Clinical Trials, Phase III as Topic
-
Dabigatran
-
Enoxaparin / administration & dosage
-
Enoxaparin / adverse effects
-
Enoxaparin / therapeutic use*
-
Hemorrhage / chemically induced
-
Humans
-
Pyridines / administration & dosage
-
Pyridines / adverse effects
-
Pyridines / therapeutic use*
-
Risk Assessment
-
Treatment Outcome
-
Venous Thromboembolism / etiology
-
Venous Thromboembolism / mortality
-
Venous Thromboembolism / prevention & control*
Substances
-
Anticoagulants
-
Benzimidazoles
-
Enoxaparin
-
Pyridines
-
Dabigatran